Henry Y Shin, Ph.D.

Henry Y Shin, Ph.D. Email and Phone Number

Co-Founder and CEO @ Excitant Therapeutics
Oklahoma City, OK, US
Henry Y Shin, Ph.D.'s Location
Oklahoma City, Oklahoma, United States, United States
Henry Y Shin, Ph.D.'s Contact Details

Henry Y Shin, Ph.D. work email

Henry Y Shin, Ph.D. personal email

n/a
About Henry Y Shin, Ph.D.

An ophthalmic researcher with 10+ years of experience leading basic & translational research projects on various ocular pathologies including Diabetic Retinopathy and Age-related Macular Degeneration. Enthusiastic about ophthalmic drug development with relevant industry experience that includes strategic planning of pre-clinical R&D roadmap, designing and execution of proof-of-concept studies, management of personnel, resource, and budget, and establishing multi-disciplinary teams to synergize and maximize pre-clinical R&D outcomes.

Henry Y Shin, Ph.D.'s Current Company Details
Excitant Therapeutics

Excitant Therapeutics

View
Co-Founder and CEO
Oklahoma City, OK, US
Henry Y Shin, Ph.D. Work Experience Details
  • Excitant Therapeutics
    Co-Founder And Ceo
    Excitant Therapeutics
    Oklahoma City, Ok, Us
  • Excitant Therapeutics
    Co-Founder And Ceo
    Excitant Therapeutics Feb 2018 - Present
    Oklahoma City
    ● Founded Excitant Therapeutics LLC to develop and commercialize PPAR-α agonists as potential therapeutic agents for diabetic retinopathy and age-related macular degeneration● Acquired exclusive rights to develop and commercialize small molecule portfolios (US 11,337,968 B2 and US 11,447,452 B2)● Established a research laboratory, hired and managed human resources (2 Ph.D. scientists and 5 research staff, cumulative) and secured multiple Small Business Innovative Research grants from National Eye Institute worth ~$2.7M to advance small molecule compounds for diabetic retinopathy and age-related macular degeneration
  • University Of Oklahoma Health Sciences Center
    Postdoctoral Researcher
    University Of Oklahoma Health Sciences Center Mar 2017 - Jan 2019
    Oklahoma City, Oklahoma Area
    ● Collaborated on a multi-PI, Hit-to-lead & lead to optimization project to find a novel drug for diabetic retinopathy● Filed a provisional patent on novel PPAR-α agonists (US Provisional Patent application 62643998; Filed on March 2018) as a co-inventor● Acquired intramural seed funding ($75,000) to advance novel PPAR-α agonists further into commercialization● Got selected as an OK catalyst researcher (monetary award for young STEM-entrepreneurs in Oklahoma)● Collaborated on an academic project to evaluate NRLP3 inflammasome inhibitors for retinopathy of prematurity● Trained and mentored graduate students and research scholars
  • University Of Oklahoma Health Sciences Center
    Doctoral Candidate
    University Of Oklahoma Health Sciences Center Aug 2011 - Jan 2017
    Oklahoma City, Oklahoma
    ● Extensively trained on development, application and optimization of molecular tools and animal models to study various ocular diseases● Generated a knock-in mouse model of human RPE65 mutation, D477G, and performed a characterization study (published in American Journal of Pathology, 2016)● Evaluated a potent visual cycle inhibitor CU239 in a mouse model of retinal degeneration for its therapeutic potential (published in BBA Molecular Basis of Disease, 2018)● Generated RPE-specific knock-out mice for Rdh10 to evaluate its novel role in visual cycle (unpublished) ● Mentored high school students for summer research projects● Guided a hands-on molecular biology research project to clone a dual-expression vector system
  • University Of Oklahoma Health Sciences Center
    Research Assistant
    University Of Oklahoma Health Sciences Center Sep 2009 - Sep 2010
    Oklahoma City, Oklahoma
    -Assisted an MD/PhD of Hematology/Oncology in developing gene screening strategies-Performed PCR and collected data for generation of G2E3 (ubiquitin ligase) conditional knock-out mice-Acquired various lab techniques essential in gene cloning and molecular biology research lab

Henry Y Shin, Ph.D. Skills

Molecular Biology Pcr Cell Biology Sds Page Cell Culture Life Sciences Science Chemistry Biotechnology Public Speaking Western Blotting Teaching Neuroscience Electroretinography Fundoscopy Polymerase Chain Reaction

Henry Y Shin, Ph.D. Education Details

Frequently Asked Questions about Henry Y Shin, Ph.D.

What company does Henry Y Shin, Ph.D. work for?

Henry Y Shin, Ph.D. works for Excitant Therapeutics

What is Henry Y Shin, Ph.D.'s role at the current company?

Henry Y Shin, Ph.D.'s current role is Co-Founder and CEO.

What is Henry Y Shin, Ph.D.'s email address?

Henry Y Shin, Ph.D.'s email address is ys****@****hsc.edu

What schools did Henry Y Shin, Ph.D. attend?

Henry Y Shin, Ph.D. attended University Of Oklahoma Health Sciences Center, Oklahoma Christian University, The University Of The South Pacific.

What skills is Henry Y Shin, Ph.D. known for?

Henry Y Shin, Ph.D. has skills like Molecular Biology, Pcr, Cell Biology, Sds Page, Cell Culture, Life Sciences, Science, Chemistry, Biotechnology, Public Speaking, Western Blotting, Teaching.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.